Tecovirimat monotherapy found ineffective for treating clade II mpox in NIH-sponsored trial
- Sierra Leone recorded 3,350 mpox cases since January 2025, with 1,779 recoveries and 16 deaths as of Saturday.
- The case increase follows a wider mpox spread since 2022, including a 2024 WHO highest alert and rising cases in several African countries.
- Vice President Mohamed Juldeh and Deputy Health Minister Charles Senessie visited a new 400-bed mpox treatment centre in Freetown opened Thursday.
- Foday Sahr said 20,000 vaccine doses expected Sunday will target high-risk contacts, with 42,872 healthcare workers already vaccinated so far.
- Authorities continue to seek international aid and provide resources to health workers while working around the clock to control the mpox outbreak.
92 Articles
92 Articles
New Mpox case confirmed in Zaragoza
Public health authorities urge vigilance as the second Mpox case in Aragon surfaces this year. A second case of Monkeypox (Mpox) has been confirmed in Zaragoza, Spain, according to the Epidemiological Bulletin of Aragon, covering the period between May 26 and June 1, 2025. The regional Department of Health stated that “the appropriate prevention and control measures” have already been taken… Source

Sierra Leone seeks help for growing mpox outbreak
Sierra Leonean authorities have called for international help to curb the spread of mpox in the country as a new toll on Saturday showed the number of cases continuing to rise.
Twelve African Nations to Boost Cross-Border Efforts Against Mpox, Health Crises
Twelve African countries have joined hands to facilitate stronger cross-border collaboration to respond, prevent and control disease outbreaks. The continent has recorded over 16,398 confirmed mpox cases and 1,180 deaths in 22 countries as of February 10, 2025. “Epidemics do not have borders, hence the need to reinforce cross-border collaboration and coordination. An agreement is […] The post Twelve African Nations to Boost Cross-Border Efforts …
A front-line antiviral drug disappoints against worrisome monkeypox strain
Tecovirimat, which has been approved to treat mpox, was no better than a placebo in a large trial. Tecovirimat, which has been approved to treat mpox, was no better than a placebo in a large trial.
Coverage Details
Bias Distribution
- 50% of the sources are Center
To view factuality data please Upgrade to Premium